Targeted Double-Stranded cDNA Sequencing-Based Phase Analysis to Identify Compound Heterozygous Mutations and

Hiroki Ura1,2, Sumihito Togi1,2, Yo Niida1,2

  • 1Center for Clinical Genomics, Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0923, Japan.

Biology
|April 3, 2021
PubMed
Summary

Distinguishing between cis and trans heterozygous mutations is crucial for diagnosing autosomal recessive diseases. This study introduces a novel cDNA sequencing method to accurately identify trans compound heterozygous mutations and assess their impact on gene expression.

Related Concept Videos